Genentech invests $750M in new factory; Bavarian Nordic delays Lyme vaccine trial

Genentech builds $750M OR facility; Bavarian Nordic delays Lyme vaccine to 2028; Xspray gets 2nd CRL for Dasynoc over NerPharMa manufacturing issues.

Raccontata daendpoints.news